Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants.

I. Doull (Cardiff, United Kingdom), R. Hanks (Cardiff, United Kingdom), C. Course (Cardiff, United Kingdom), S. Moat (Cardiff, United Kingdom)

Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Session: Cystic fibrosis in paediatric patients: current research
Session type: Thematic Poster
Number: 4629
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Doull (Cardiff, United Kingdom), R. Hanks (Cardiff, United Kingdom), C. Course (Cardiff, United Kingdom), S. Moat (Cardiff, United Kingdom). Newborn screening for Cystic Fibrosis over 20 years and the identification of affected not detected infants.. 4629

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Newborn Screening for Cystic Fibrosis in Wales over 20 years. Changes in incidence dependent on screening protocol
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018


Stable lung function is maintained over 2 years in newborn screened (NBS) CF infants
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Newborn screening for cystic fibrosis in Spain
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Respiratory rate in infants with Cystic Fibrosis and healthy controls throughout the first year of life.
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017

Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Within-subject variability of lung function in newborn screened (NBS) CF infants
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Microbiological yield of oropharyngeal swab compared to induced sputum in children with cystic fibrosis (CF) < 5 years of age
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Newborn screening in Europe
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006


Lung clearance index in young children with atypical CF
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016



Ventilation distribution is not influenced by structural lung disease in infants with cystic fibrosis (CF) diagnosed following newborn screening (NBS)
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009

Screening colonoscopy in adults with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Risk factors for early lung function decline in young children with Cystic Fibrosis
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018



Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010


Normal lung function in infants with cystic fibrosis shortly after birth
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013

Changes in the Lung Clearance Index outside 15% are clinically relevant in children with cystic fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Cystic fibrosis newborn screening for R117H in England
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020


Lung function at the age of 35 years in individuals with alpha-1-antitrypsin deficiency identified by neonatal screening
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010

Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015

Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014